Metabolic disorders
medical conditions

Metabolic disorders

Explore the available health information, treatment context, and integrative evidence for Metabolic disorders.

Background
  • Metabolic disorders are illnesses that occur when the body is unable to process fats (lipids), proteins, sugars (carbohydrates), or nucleic acids properly. Most metabolic disorders are caused by genetic mutations that result in missing or dysfunctional enzymes that are needed for the cell to perform metabolic processes.
  • Most metabolic disorders are inherited, which means they are passed down through families. Examples of metabolic disorders include adrenoleukodystrophy (ALD), alkaptonuria, cystinosis, DIDMOAD syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness syndrome), glucose 6-phosphage dehydrogenase
    (G6PD) deficiency, hyperornithinemia-hyperammonemia-homocitrullinuria (HHH), inborn errors of urea synthesis, Kearns-Sayre, maple syrup urine disease, McArdle's disease, MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes) syndrome, metabolic syndrome, phenylketonuria (PKU), pyruvate carboxylase deficiency, subacute necrotizing encephalopathy, Tay-Sachs disease, and trimethylaminuria.
  • Prognosis and treatment varies, depending on the type and severity of the disorder.
Prevention
  • Individuals can take steps to reduce their risk of developing metabolic syndrome by eating healthy foods and exercising regularly. Patients should also visit their doctors regularly to determine if they are at risk of developing metabolic syndrome.
  • There are currently no known methods of prevention for metabolic disorders that are inherited. However, individuals can be tested to determine if they are carriers of the disease. Although carriers do not experience symptoms of the disease, they may pass them on to their children.
  • Patients who have genetically inherited metabolic disorders or are carriers of certain disorders may wish to receive genetic counseling. A counselor will provide information and answer questions about the risk of passing the disorders on to their children.
  • Patients with metabolic disorders should take their medications exactly as prescribed and/or strictly follow their diets in order to help prevent complications.
References
  1. American Heart Association. . Accessed April 16, 2009.
  2. Aubourg P. X-linked adrenoleukodystrophy. Article in French. Ann Endocrinol (Paris). 2007 May 29; Epub ahead of print.
    View Abstract
  3. Daly CA, Hildebrandt P, Bertrand M, et al. Adverse prognosis associated with the metabolic syndrome in established coronary artery disease. Data from the EUROPA trial. Heart. 2007 May 31; Epub ahead of print.
    View Abstract
  4. Endocrine and Metabolic Diseases Information Service. . Accessed April 16, 2009.
  5. Espinola-Klein C, Rupprecht HJ, Bickel C, et al. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol. 2007 Jun 15;99(12):1623-8. Epub 2007 May 2.
    View Abstract
  6. Giordano C, de Santo NG, Pluvio M, et al. Lysine in treatment of hyperornithinemia. Nephron. 1978;22(1-3):97-106.
    View Abstract
  7. Natural Standard: The Authority on Integrative Medicine. . Copyright © 2009. Accessed April 16, 2009.
  8. Oka Y. Wolfram syndrome. Article in Japanese. Nippon Rinsho. 2006 Sep 28;Suppl 3:138-42.
    View Abstract
  9. Olsson GM, Montgomery SM, Alm J. Family conditions and dietary control in phenylketonuria. J Inherit Metab Dis. 2007 Jun 14; Epub ahead of print.
    View Abstract
  10. Verma SB. Early detection of alkaptonuria. Indian J Dermatol Venereol Leprol. 2005 May-Jun;71(3):189-91.
    View Abstract
  11. Zachwieja J. Cystinosis--an orphan disease. Pathogenesis and current treatment. Article in Polish. Przegl Lek. 2006;63 Suppl 3:29-31.
    View Abstract